Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect Of Prostaglandin E1 Treatment On Pyloric Wall Thickness in Newborns With Ductal Dependent Critical Congenital Heart Diseases

NCT04496050 is registered in ClinicalTrials.gov with Hacettepe University as lead sponsor.

NCT NCT04496050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04496050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect Of Prostaglandin E1 Treatment On Pyloric Wall Thickness in Newborns With Ductal Dependent Critical Congenital Heart Diseases
Lead sponsor
Hacettepe University
Phase
Observational
Overall status
Unknown status
Start date
May 6, 2019
Completion date
November 30, 2020
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, pyloric stenosis;acquired